ArticleMaterials today. Bio2026
NIR-II-responsive conductive silk fibroin microneedle patches for postoperative melanoma ablation, infected-wound healing, and real-time monitoring.
Article in Materials today. Bio, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- NIR-Assisted Multimodal Strategies for Enhanced Antibacterial Therapy.Small (Weinheim an der Bergstrasse, Germany) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Postoperative management of melanoma remains a significant clinical challenge due to the concurrent risks of residual tumor recurrence, bacterial infection, impaired healing, and the lack of real-time monitoring. Here, we presented an all-in-one theranostic microneedle patches (MNs) engineered from a natural biomaterial framework. The patch is fabricated via photo-crosslinking of methacrylated silk fibroin (SFMA) and acrylated β-cyclodextrin (Ac-CD), which incorporates lignosulfonate-doped poly-N-phenylglycine (LS@PNPG) nanocomposites as multifunctional photothermal and conductive components, alongside β-cyclodextrin-encapsulated curcumin (Cur) for hydrophobic drug delivery. The optimized MNs exhibited robust mechanical strength (1.73 N per needle), ensuring reliable skin penetration. The LS@PNPG component exhibited a high NIR-II photothermal conversion efficiency (30.65 % at 1064 nm), enabling effective photothermal heating (>58 °C in vitro; ∼50 °C in vivo) that triggered on-demand Cur release. This synergistic photothermal-chemotherapy achieved 98.9 % tumor eradication in vivo. Concurrently, the patch demonstrated potent antioxidant (87.2 % DPPH scavenging) and antibacterial activities (>98 % elimination of
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.